StockStory Favors Cardinal Health, Flags Two Healthcare Names
The publisher pointed to Cardinal Health’s earnings growth while citing slower sales or weaker profitability at Omnicell and Lantheus.
Makkler Newsroom · Oct 6, 03:43 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $104.98 (+3.3%)
Prices may be delayed and are for informational purposes only - not investment advice.
The publisher pointed to Cardinal Health’s earnings growth while citing slower sales or weaker profitability at Omnicell and Lantheus.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.